Sudden death after sustained restraint following self-administration of the designer drug α-pyrrolidinovalerophenone
- 1 March 2014
- journal article
- Published by Elsevier BV in International Journal of Cardiology
- Vol. 172 (1), 263-265
- https://doi.org/10.1016/j.ijcard.2013.12.262
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Small focal coagulation necrosis in the myocardium of a young methamphetamine userInternational Journal of Cardiology, 2013
- New designer drug of abuse: 3,4-Methylenedioxypyrovalerone (MDPV). Findings from apprehended drivers in FinlandForensic Science International, 2011
- Acute poisoning involving the pyrrolidinophenone-type designer drug 4′-methyl-alpha-pyrrolidinohexanophenone (MPHP)Forensic Science International, 2011
- Restraint stress induces connexin-43 translocation via ?-adrenoceptors in rat heart.Circulation Journal, 2010
- Psychological Stress and Cardiovascular DiseaseJournal of the American College of Cardiology, 2008
- Stress (Takotsubo) cardiomyopathy—a novel pathophysiological hypothesis to explain catecholamine-induced acute myocardial stunningNature Clinical Practice Cardiovascular Medicine, 2008
- Adam (MDMA) and Eve (MDEA) misuse: an immunohistochemical study on three fatal casesForensic Science International, 1999
- Sympatho-adrenal involvement in methamphetamine-induced hyperthermia through skeletal muscle hypermetabolismEuropean Journal of Pharmacology, 1998